Lantern Pharma Inc.
(NASDAQ:LTRN)
$4.08
-0.03 (-0.73%)
At Close: 4:00 PM
LTRN Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
LTRN Stock Price Today
Lantern Pharma Inc. (LTRN) stock rallied over 3.97% intraday to trade at $4.19 a share on NASDAQ. The stock opened with a loss of -30.90% at $2.84 and touched an intraday high of $2.84, rising 1.95% against the last close of $4.11. The Lantern Pharma Inc. in stock market went to a low of $2.65 during the session.
LTRN Stock Snapshot
$4.11
Prev. Close
44.35 Million
Market Cap
$2.65
Day Low
$2.84
Open
N/A
Number of Shares
$2.84
Day High
N/A
P/E ratio
-1.40
EPS (TTM)
4.13
Cash Flow per Share
N/A
Free Float in %
4.18
Book Value
62581.00
Volume
LTRN Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta1.24
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Peers
Frequently Asked Questions
What is the current Lantern Pharma Inc. (LTRN) stock price?
Lantern Pharma Inc. (NASDAQ: LTRN) stock price is $4.19 in the last trading session. During the trading session, LTRN stock reached the peak price of $2.84 while $2.65 was the lowest point it dropped to. The percentage change in LTRN stock occurred in the recent session was 3.97% while the dollar amount for the price change in LTRN stock was $0.16.
LTRN's industry and sector of operation?
The NASDAQ listed LTRN is part of Biotechnology industry that operates in the broader Healthcare sector. Lantern Pharma Inc. , a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process.
Who are the executives of LTRN?
Mr. Panna Sharma PH.D.
Pres, Chief Executive Officer & Director
Mr. David R. Margrave
Chief Financial Officer & Sec.
Mr. Panna Sharma PH.D.
Pres, CEO & Director
Mr. David R. Margrave
CFO & Sec.
How LTRN did perform over past 52-week?
LTRN's closing price is 0.23% higher than its 52-week low of $2.571 where as its distance from 52-week high of $6.2 is -0.24%.
How many employees does LTRN have?
Number of LTRN employees currently stands at N/A. LTRN operates from 1920 McKinney Avenue, Dallas, TX 75201, US.
Link for LTRN official website?
Official Website of LTRN is: https://www.lanternpharma.com
How do I contact LTRN?
LTRN could be contacted at phone #972 277 1136 and can also be accessed through its website. LTRN operates from 1920 McKinney Avenue, Dallas, TX 75201, US.
How many shares of LTRN are traded daily?
LTRN stock volume for the day was 62581.00 shares. The average number of LTRN shares traded daily for last 3 months was 35.67 Thousands.
What is the market cap of LTRN currently?
The market value of LTRN currently stands at $44.35 Million with its latest stock price at $4.19 and N/A of its shares outstanding.